搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Klebsiella pneumoniae UPF0294 protein KPK_4510 (KPK_4510) CSB-YP471360KBH
CSB-EP471360KBH
CSB-BP471360KBH
CSB-MP471360KBH
CSB-EP471360KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Lipid-A-disaccharide synthase (lpxB) CSB-YP471361KBH
CSB-EP471361KBH
CSB-BP471361KBH
CSB-MP471361KBH
CSB-EP471361KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae 30S ribosomal protein S2 (rpsB) CSB-YP471362KBH
CSB-EP471362KBH
CSB-BP471362KBH
CSB-MP471362KBH
CSB-EP471362KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae GMP reductase (guaC) CSB-YP471363KBH
CSB-EP471363KBH
CSB-BP471363KBH
CSB-MP471363KBH
CSB-EP471363KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP471364KBH
CSB-EP471364KBH
CSB-BP471364KBH
CSB-MP471364KBH
CSB-EP471364KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae 2-isopropylmalate synthase (leuA), partial CSB-YP471365KBH
CSB-EP471365KBH
CSB-BP471365KBH
CSB-MP471365KBH
CSB-EP471365KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Ribulokinase (araB), partial CSB-YP471366KBH
CSB-EP471366KBH
CSB-BP471366KBH
CSB-MP471366KBH
CSB-EP471366KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Bis (5'-nucleosyl)-tetraphosphatase, symmetrical CSB-YP471367KBH
CSB-EP471367KBH
CSB-BP471367KBH
CSB-MP471367KBH
CSB-EP471367KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Non-specific ribonucleoside hydrolase rihC (rihC) CSB-YP471368KBH
CSB-EP471368KBH
CSB-BP471368KBH
CSB-MP471368KBH
CSB-EP471368KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Probable phosphoglycerate mutase GpmB (gpmB) CSB-YP471369KBH
CSB-EP471369KBH
CSB-BP471369KBH
CSB-MP471369KBH
CSB-EP471369KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Phosphopentomutase (deoB) CSB-YP471370KBH
CSB-EP471370KBH
CSB-BP471370KBH
CSB-MP471370KBH
CSB-EP471370KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Ribosomal RNA small subunit methyltransferase C (rsmC) CSB-YP471371KBH
CSB-EP471371KBH
CSB-BP471371KBH
CSB-MP471371KBH
CSB-EP471371KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Inositol 2-dehydrogenase (iolG) CSB-YP471372KBH
CSB-EP471372KBH
CSB-BP471372KBH
CSB-MP471372KBH
CSB-EP471372KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Peptide methionine sulfoxide reductase MsrA (msrA) CSB-YP471373KBH
CSB-EP471373KBH
CSB-BP471373KBH
CSB-MP471373KBH
CSB-EP471373KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Adenylosuccinate synthetase (purA) CSB-YP471374KBH
CSB-EP471374KBH
CSB-BP471374KBH
CSB-MP471374KBH
CSB-EP471374KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Fumarate reductase subunit C (frdC), partial CSB-YP471375KBH1
CSB-EP471375KBH1
CSB-BP471375KBH1
CSB-MP471375KBH1
CSB-EP471375KBH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coprothermobacter proteolyticus FMN-dependent NADH-azoreductase (azoR) CSB-YP471376DWR
CSB-EP471376DWR
CSB-BP471376DWR
CSB-MP471376DWR
CSB-EP471376DWR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coprothermobacter proteolyticus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP471377DWR
CSB-EP471377DWR
CSB-BP471377DWR
CSB-MP471377DWR
CSB-EP471377DWR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coprothermobacter proteolyticus 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP471378DWR
CSB-EP471378DWR
CSB-BP471378DWR
CSB-MP471378DWR
CSB-EP471378DWR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coprothermobacter proteolyticus 50S ribosomal protein L27 (rpmA) CSB-YP471379DWR
CSB-EP471379DWR
CSB-BP471379DWR
CSB-MP471379DWR
CSB-EP471379DWR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>